Opioid Manufacturer Indivior ’s Chief Executive Officer Pleads Guilty in Connection with Drug Safety Claims

FDA OCI, Shaun Thaxter, CEO, Indivior, guilty plea, opioid, Suboxone Film, misbranded, Reckitt Benckiser, recovery, addicts, marketing, withdrawal, treatment, buprenorphine, sales, preferred drug status, false information, misleading information
Source: Office of Criminal Investigations (OCI) Press Releases - Category: Medical Law Authors: Source Type: news

Related Links:

More News: Addiction | Marketing | Medical Law | Suboxone